![ASCO 2022: A phase I trial of elimusertib in combination with cisplatin or with cisplatin plus gemcitabine in advanced solid tumors with an emphasis on urothelial carcinoma. ASCO 2022: A phase I trial of elimusertib in combination with cisplatin or with cisplatin plus gemcitabine in advanced solid tumors with an emphasis on urothelial carcinoma.](https://larvolclin.s3.us-west-2.amazonaws.com/resize_1655310308142162762062aa07e4daeaf.jpg)
ASCO 2022: A phase I trial of elimusertib in combination with cisplatin or with cisplatin plus gemcitabine in advanced solid tumors with an emphasis on urothelial carcinoma.
![High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial - The Lancet Oncology High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/dbec891b-f83b-4e40-8287-f397533b9221/gr1.gif)
High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial - The Lancet Oncology
![Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines | medRxiv Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2021/03/17/2021.03.17.21253131/F1.large.jpg)
Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines | medRxiv
![Cancers | Free Full-Text | Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid Tumors Cancers | Free Full-Text | Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid Tumors](https://pub.mdpi-res.com/cancers/cancers-13-00287/article_deploy/html/images/cancers-13-00287-g001.png?1611289275)
Cancers | Free Full-Text | Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid Tumors
![A Trial of a new drug to Treat Patients With Advanced or Metastatic Solid Cancer Tumors (Ulysse) | Clinical trials - Pierre Fabre A Trial of a new drug to Treat Patients With Advanced or Metastatic Solid Cancer Tumors (Ulysse) | Clinical trials - Pierre Fabre](https://clinicaltrials.pierre-fabre.com/sites/cdt/files/2022-11/Ulysse%20schema.jpg)
A Trial of a new drug to Treat Patients With Advanced or Metastatic Solid Cancer Tumors (Ulysse) | Clinical trials - Pierre Fabre
![Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial - The Lancet Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/011535c8-82ac-4b87-89a7-dcb43a5a808a/gr1.gif)
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial - The Lancet
![Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial - The Lancet Oncology Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial - The Lancet Oncology](https://www.thelancet.com/cms/asset/b00f518e-35e4-480a-bbc3-65357e7af1ec/gr1.jpg)
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial - The Lancet Oncology
![Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial | Nature Medicine Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01829-9/MediaObjects/41591_2022_1829_Fig1_HTML.png)
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial | Nature Medicine
![Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial ... Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial ...](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-022-01667-1/MediaObjects/41375_2022_1667_Fig1_HTML.png)
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial ...
![Amazon.com : Ethique Hair Sampler - Shampoo & Conditioner - Plastic-Free, Vegan, Cruelty-Free, Eco-Friendly, 5 Travel Bars (Pack of 1) : Beauty & Personal Care Amazon.com : Ethique Hair Sampler - Shampoo & Conditioner - Plastic-Free, Vegan, Cruelty-Free, Eco-Friendly, 5 Travel Bars (Pack of 1) : Beauty & Personal Care](https://m.media-amazon.com/images/I/71AOWLx2JwL.jpg)
Amazon.com : Ethique Hair Sampler - Shampoo & Conditioner - Plastic-Free, Vegan, Cruelty-Free, Eco-Friendly, 5 Travel Bars (Pack of 1) : Beauty & Personal Care
![Pictorial French Follies 3/1930-2nd issue-spicy stories, pix-art-pulp-VG/FN | Comic Collectibles - Magazines / HipComic Pictorial French Follies 3/1930-2nd issue-spicy stories, pix-art-pulp-VG/FN | Comic Collectibles - Magazines / HipComic](https://storage.googleapis.com/hipcomic/p/1f62e6411b3213936b0ed47c5ed1f002-800.jpg)
Pictorial French Follies 3/1930-2nd issue-spicy stories, pix-art-pulp-VG/FN | Comic Collectibles - Magazines / HipComic
![Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials | Nature Medicine Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials | Nature Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-02103-8/MediaObjects/41591_2022_2103_Fig1_HTML.png)